[go: up one dir, main page]

AU2001238596A1 - 18607, a novel human calcium channel - Google Patents

18607, a novel human calcium channel

Info

Publication number
AU2001238596A1
AU2001238596A1 AU2001238596A AU3859601A AU2001238596A1 AU 2001238596 A1 AU2001238596 A1 AU 2001238596A1 AU 2001238596 A AU2001238596 A AU 2001238596A AU 3859601 A AU3859601 A AU 3859601A AU 2001238596 A1 AU2001238596 A1 AU 2001238596A1
Authority
AU
Australia
Prior art keywords
calcium channel
novel human
human calcium
novel
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001238596A
Inventor
Rory A. J. Curtis
Maria Alexandra Glucksmann
Jose M. Lora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001238596A1 publication Critical patent/AU2001238596A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001238596A 2000-02-22 2001-02-20 18607, a novel human calcium channel Abandoned AU2001238596A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US51070600A 2000-02-22 2000-02-22
US09510706 2000-02-22
US58337300A 2000-05-31 2000-05-31
US09583373 2000-05-31
US63466900A 2000-08-08 2000-08-08
US09634669 2000-08-08
PCT/US2001/005529 WO2001062794A2 (en) 2000-02-22 2001-02-20 18607, a human calcium channel

Publications (1)

Publication Number Publication Date
AU2001238596A1 true AU2001238596A1 (en) 2001-09-03

Family

ID=27414465

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001238596A Abandoned AU2001238596A1 (en) 2000-02-22 2001-02-20 18607, a novel human calcium channel

Country Status (3)

Country Link
US (1) US20020142377A1 (en)
AU (1) AU2001238596A1 (en)
WO (1) WO2001062794A2 (en)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE396266T1 (en) * 2000-07-28 2008-06-15 Ulrich Wissenbach TRP8 CANCER MARKER
AU2002336574A1 (en) * 2001-09-17 2003-04-01 Millennium Pharmaceuticals, Inc. Methods of using 5433, a human calcium channel family member
US7452675B2 (en) * 2002-01-25 2008-11-18 The Queen's Medical Center Methods of screening for TRPM4b modulators
WO2003087158A2 (en) * 2002-04-16 2003-10-23 Bayer Healthcare Ag Regulation of human transient receptor potential channel
EP1578371A4 (en) * 2002-08-19 2009-05-20 Genentech Inc Compositions and methods for the diagnosis and treatment of tumor
CN104998273A (en) 2003-11-06 2015-10-28 西雅图基因公司 Monomethylvaline compounds capable of coupling to ligands
CA2567520A1 (en) 2004-06-01 2005-12-15 Genentech, Inc. Maytansinoid-antibody conjugates
US20100111856A1 (en) 2004-09-23 2010-05-06 Herman Gill Zirconium-radiolabeled, cysteine engineered antibody conjugates
EP3088004B1 (en) 2004-09-23 2018-03-28 Genentech, Inc. Cysteine engineered antibodies and conjugates
US8148083B2 (en) * 2006-05-25 2012-04-03 The Queen's Medical Center Methods of screening for TRPM4 modulators of insulin secretion
US8638228B2 (en) 2007-02-02 2014-01-28 Hartford Fire Insurance Company Systems and methods for sensor-enhanced recovery evaluation
CA2809819A1 (en) 2009-09-09 2011-03-17 Centrose, Llc Extracellular targeted drug conjugates
HRP20130953T1 (en) 2010-04-15 2013-11-22 Spirogen Sàrl Pyrrolobenzodiazepines and conjugates thereof
CA2799540A1 (en) 2010-06-08 2011-12-15 Genentech, Inc. Cysteine engineered antibodies and conjugates
EP2640727B1 (en) 2010-11-17 2015-05-13 Genentech, Inc. Alaninyl maytansinol antibody conjugates
MX2013013054A (en) 2011-05-12 2014-02-20 Genentech Inc Multiple reaction monitoring lc-ms/ms method to detect therapeutic antibodies in animal samples using framework signature peptides.
PL2750713T3 (en) 2011-10-14 2016-03-31 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
WO2013130093A1 (en) 2012-03-02 2013-09-06 Genentech, Inc. Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
DK2839860T3 (en) 2012-10-12 2019-06-17 Medimmune Ltd Pyrrolobenzodiazepines and their conjugates
MX364329B (en) 2012-10-12 2019-04-23 Medimmune Ltd Pyrrolobenzodiazepine-antibody conjugates.
PL2906251T3 (en) 2012-10-12 2018-02-28 Adc Therapeutics Sa Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
ES2680153T3 (en) 2012-10-12 2018-09-04 Adc Therapeutics Sa Anti-PSMA-pyrrolobenzodiazepine antibody conjugates
WO2014057119A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-antibody conjugates
WO2014057120A1 (en) 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-antibody conjugates
DK2906253T3 (en) 2012-10-12 2018-10-22 Adc Therapeutics Sa Pyrrolobenzodiazepine anti-PSMA antibody conjugates
EA031585B1 (en) 2012-12-21 2019-01-31 Медимьюн Лимитед Pyrrolobenzodiazepines and conjugates thereof
CN105246894A (en) 2012-12-21 2016-01-13 斯皮罗根有限公司 Asymmetric pyrrolobenzodiazepine dimers for the treatment of proliferative and autoimmune diseases
NZ710745A (en) 2013-03-13 2019-03-29 Genentech Inc Pyrrolobenzodiazepines and conjugates thereof
ES2687439T3 (en) 2013-03-13 2018-10-25 Medimmune Limited Pyrrolobenzodiazepines and conjugates thereof
CN105142674B (en) 2013-03-13 2018-11-13 麦迪穆有限责任公司 Pyrrolobenzodiazepines and their conjugates
BR112016002829A2 (en) 2013-08-12 2017-09-19 Genentech Inc COMPOUND AND PROCESS FOR PREPARING ANTIBODY-DRUG CONJUGATE COMPOUND, PHARMACEUTICAL COMPOSITION, CANCER TREATMENT METHOD, CANCER TREATMENT KIT, DRUG LINKER INTERMEDIATE, CBI DIMER DRUG MOUNT AND COMPOUND
US9956299B2 (en) 2013-10-11 2018-05-01 Medimmune Limited Pyrrolobenzodiazepine—antibody conjugates
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
US10010624B2 (en) 2013-10-11 2018-07-03 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
US9950078B2 (en) 2013-10-11 2018-04-24 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
MX371092B (en) 2013-12-16 2020-01-16 Genentech Inc Peptidomimetic compounds and antibody-drug conjugates thereof.
JP6980384B2 (en) 2013-12-16 2021-12-15 ジェネンテック， インコーポレイテッド 1- (Chloromethyl) -2,3-dihydro-1H-benzo [E] indole dimer antibody-drug conjugate compound, and methods of use and treatment
CN107106700B (en) 2013-12-16 2020-10-30 基因泰克公司 Peptidomimetic compounds and antibody-drug conjugates thereof
CN106687141A (en) 2014-09-10 2017-05-17 麦迪穆有限责任公司 Pyrrolobenzodiazepines and conjugates thereof
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
JP6622293B2 (en) 2014-09-12 2019-12-18 ジェネンテック， インコーポレイテッド Anthracycline disulfide intermediates, antibody-drug conjugates, and methods
EP3388449A3 (en) 2014-09-12 2018-10-24 F. Hoffmann-La Roche AG Cysteine engineered antibodies and conjugates
KR20170067771A (en) 2014-09-17 2017-06-16 제넨테크, 인크. Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
CN107148285B (en) 2014-11-25 2022-01-04 Adc治疗股份有限公司 Pyrrolobenzodiazepine-antibody conjugates
AU2015358532C1 (en) 2014-12-03 2020-10-29 Genentech, Inc. Quaternary amine compounds and antibody-drug conjugates thereof
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
MA43345A (en) 2015-10-02 2018-08-08 Hoffmann La Roche PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
MA43354A (en) 2015-10-16 2018-08-22 Genentech Inc CONJUGATE DRUG CONJUGATES WITH CLOUDY DISULPHIDE
MA45326A (en) 2015-10-20 2018-08-29 Genentech Inc CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
CN108700598A (en) 2016-03-25 2018-10-23 豪夫迈·罗氏有限公司 The drug of the total antibody of multichannel and antibody conjugate quantifies measuring method
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
CN109152843A (en) 2016-05-20 2019-01-04 豪夫迈·罗氏有限公司 PROTAC antibody conjugates and methods of using the same
CN109313200B (en) 2016-05-27 2022-10-04 豪夫迈·罗氏有限公司 Bioanalytical methods for characterizing site-specific antibody-drug conjugates
US10639378B2 (en) 2016-06-06 2020-05-05 Genentech, Inc. Silvestrol antibody-drug conjugates and methods of use
CN109689111B (en) 2016-08-11 2024-04-05 基因泰克公司 Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
EP3522933B1 (en) 2016-10-05 2021-12-15 F. Hoffmann-La Roche AG Methods for preparing antibody drug conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
BR112019016373B1 (en) 2017-02-08 2022-01-25 Medimmune Limited Antibody-drug conjugate that binds to axl, composition and pharmaceutical composition comprising the same and therapeutic use of said conjugate
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
ES2926144T3 (en) 2017-04-18 2022-10-24 Medimmune Ltd Pyrrolobenzodiazepine conjugates
JP7408396B2 (en) 2017-04-20 2024-01-05 アーデーセー セラピューティクス ソシエテ アノニム combination therapy
PL3638373T3 (en) 2017-06-14 2025-04-14 Adc Therapeutics Sa Dosing regimens for anti-CD19 ADC administration
EP3668874B1 (en) 2017-08-18 2021-12-22 Medimmune Limited Pyrrolobenzodiazepine conjugates
US10301319B2 (en) 2017-09-20 2019-05-28 Ph Pharma Co., Ltd. Thailanstatin analogs
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
GB201814281D0 (en) 2018-09-03 2018-10-17 Femtogenix Ltd Cytotoxic agents
CN113056287A (en) 2018-10-24 2021-06-29 豪夫迈·罗氏有限公司 Conjugated chemical degradation inducers and methods of use
JP2022513198A (en) 2018-12-10 2022-02-07 ジェネンテック， インコーポレイテッド Photocrosslinkable peptide for site-specific conjugation to Fc-containing proteins
GB201901197D0 (en) 2019-01-29 2019-03-20 Femtogenix Ltd G-A Crosslinking cytotoxic agents
MX2021010477A (en) 2019-03-15 2021-10-01 Medimmune Ltd Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer.
JP2024541058A (en) 2021-11-03 2024-11-06 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ． Specific conjugation of antibodies
TW202432187A (en) 2022-12-23 2024-08-16 美商建南德克公司 Cereblon degrader conjugates, and uses thereof
WO2024220546A2 (en) 2023-04-17 2024-10-24 Peak Bio, Inc. Antibodies and antibody-drug conjugates and methods of use and synthetic processes and intermediates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919638A (en) * 1996-10-08 1999-07-06 Abbott Laboratories Reagents and methods useful for detecting prostate tumors
CA2281952C (en) * 1997-02-25 2011-07-19 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
JP2002536966A (en) * 1998-12-30 2002-11-05 ベス・イスラエル・ディーコニス・メディカル・センター・インコーポレーテッド Characterization of the calcium channel family

Also Published As

Publication number Publication date
WO2001062794A2 (en) 2001-08-30
US20020142377A1 (en) 2002-10-03
WO2001062794A3 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU2001238596A1 (en) 18607, a novel human calcium channel
AU2002224480A1 (en) Lace-less shoe
AU2001261572A1 (en) 38594, a novel human transporter and uses thereof
AU2001271455A1 (en) A human calcium channel protein and uses thereof
AU2002227925A1 (en) Human beta-defensin-3
AU1782201A (en) 2786, a novel human aminopeptidase
AU2002338572A1 (en) 66784, a novel human potassium channel and uses therefor
AU2001241728A1 (en) 25312, a novel human agmatinase-like homolog
AU2001236777A1 (en) 39406 protein, a seven transmembrane protein
AU2001266728A1 (en) 56201, a novel human sodium ion channel family member and uses thereof
AU2001268440A1 (en) 53320, a human acyltransferase and uses therefor
AUPR069500A0 (en) Tissue modification
AU2001238707A1 (en) 32705, 23224, 27423, 32700, 32712, novel human g-proteins
AU2001284590A1 (en) Shoe
AU2001268435A1 (en) 23680, a novel human aminotransferase and uses therefor
AU6204300A (en) 22012, a novel human carboxypeptidase
AU2001294724A1 (en) 56115, a novel human twik potassium channel and uses therefor
AU2001239965A1 (en) 23927, a novel human ion channel
AU2001275338A1 (en) 21784, a novel human calcium channel family member and uses thereof
AU2001294723A1 (en) 25658, a novel human calcium channel subunit and uses thereof
AU2001253909A1 (en) 26335, a novel human serine/threonine dehydratase and uses thereof
AU2002211512A1 (en) 25219, a novel human aminotransferase and uses therefor
AU2002211492A1 (en) 57800, a novel human cadherin and uses therefor
AU2001296307A1 (en) 55054, a human metalloprotease and uses therefor
AU2001291135A1 (en) 63760, a novel human transporter and uses thereof